Compare PACB & PAYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PACB | PAYS |
|---|---|---|
| Founded | 2000 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Business Services |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 696.3M | 780.3M |
| IPO Year | 2010 | 2020 |
| Metric | PACB | PAYS |
|---|---|---|
| Price | $1.90 | $10.02 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 5 |
| Target Price | $2.74 | ★ $14.81 |
| AVG Volume (30 Days) | ★ 12.4M | 1.2M |
| Earning Date | 11-04-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 85.71 |
| EPS | N/A | ★ 0.30 |
| Revenue | ★ $93,468,000.00 | $24,120,434.00 |
| Revenue This Year | N/A | $40.90 |
| Revenue Next Year | $14.03 | $12.70 |
| P/E Ratio | ★ N/A | $32.70 |
| Revenue Growth | ★ 3.04 | N/A |
| 52 Week Low | $1.07 | $3.08 |
| 52 Week High | $3.44 | $16.15 |
| Indicator | PACB | PAYS |
|---|---|---|
| Relative Strength Index (RSI) | 42.61 | 32.09 |
| Support Level | $1.27 | $8.26 |
| Resistance Level | $2.00 | $14.06 |
| Average True Range (ATR) | 0.26 | 1.08 |
| MACD | -0.09 | -0.46 |
| Stochastic Oscillator | 15.14 | 12.93 |
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.
PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The company creates customized payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The The company generates revenues from pharma card programs through card program management fees, transaction claim processing fees, interchange fees, customer service fees, other billable service fees and settlement income and other revenues are generated through cardholder fees, interchange fees, program management fees, load fees and breakage.